```html

Kystic hygroma (Cystic hygroma) – A Complete Patient Guide

Overview

Cystic hygroma (also called lymphangioma or kystic hygroma) is a benign, fluid‑filled malformation of the lymphatic system. It typically appears as a soft, compressible mass under the skin, most often in the neck or head region, but it can also occur in the axilla, mediastinum, or groin.

Who it affects: The condition is congenital, meaning it is present at birth, although it may not be noticed until later in childhood. Approximately 90 % of cases are diagnosed before age 2, and it is slightly more common in females (about 1.5 : 1 male‑to‑female ratio).

Prevalence: Cystic hygromas are rare, accounting for 1‑5 % of all congenital lymphatic anomalies. In the United States, the estimated incidence is about 1 in 6,000–8,000 live births.<sup>1</sup>

Symptoms

Because cystic hygromas are primarily structural lesions, symptoms depend on size, location, and whether the lesion compresses nearby structures. Below is a comprehensive list.

General Features

• Soft, painless swelling – Often described as “gelatinous” or “floppy.”
• Transilluminates – Light shines through when a flashlight is placed against the mass, a classic sign of fluid‑filled lesions.
• Fluctuates in size – May enlarge with infection, trauma, or upper‑respiratory infections.

Location‑Specific Symptoms

• Neck (most common) – May cause visible bulging on one side, difficulty turning the head, or a feeling of tightness.
• Oral cavity or floor of mouth – Can interfere with feeding, speech, or cause drooling.
• Axilla (underarm) – May restrict arm movement or cause a “bag‑like” swelling.
• Chest or mediastinum – May produce coughing, wheezing, or shortness of breath if the airway is compressed.
• Groin or thigh – May be mistaken for a hernia or lipoma.

Complicating Symptoms

• Rapid enlargement (often due to infection or hemorrhage)
• Pain or tenderness if the cyst ruptures or bleeds
• Difficulty swallowing (dysphagia) or breathing (dyspnea) when the mass presses on the esophagus or trachea
• Facial asymmetry or eye problems (e.g., proptosis) when the lesion involves the orbit

Causes and Risk Factors

Cystic hygroma is not caused by anything a parent or patient does; it is a developmental defect.

Pathophysiology

• During embryogenesis, lymphatic vessels arise from the veins and spread throughout the body. In cystic hygroma, a segment of these vessels fails to connect properly, forming a cystic pocket that fills with lymphatic fluid.
• The lesions are made up of thin‑walled, endothelial‑lined cysts that can be macrocystic (>2 cm) or microcystic (tiny channels).

Genetic Associations

• Turner syndrome (45,X) – Up to 30 % of females with Turner syndrome have lymphatic malformations, including cystic hygroma.<sup>2</sup>
• Down syndrome (Trisomy 21) – Slightly increased risk.
• Chromosomal deletions – 22q11.2 deletion syndrome (DiGeorge) and others have been reported.

Other Risk Factors

• Family history of lymphatic malformations (rare, likely autosomal‑dominant with variable penetrance).
• Maternal exposure to certain teratogens has not been conclusively linked, but general prenatal care is recommended.

Diagnosis

Diagnosis is primarily clinical, supported by imaging to evaluate depth, extent, and relationship to vital structures.

Physical Examination

• Inspection of swelling, assessment of mobility, and transillumination test.
• Palpation to determine consistency (soft, fluctuant) and compressibility.

Imaging Studies

• Ultrasound – First‑line; shows anechoic or hypoechoic cystic spaces, helps differentiate from solid masses.
• Magnetic Resonance Imaging (MRI) – Gold standard for delineating extent, especially in the neck and thorax. T2‑weighted images highlight fluid‑filled cysts.
• Computed Tomography (CT) scan – Useful when MRI is contraindicated; can assess bone involvement.
• Lymphangiography – Rarely needed; performed when planning surgical or sclerotherapy approaches.

Laboratory Tests

Usually not required, but a complete blood count (CBC) and inflammatory markers (CRP, ESR) may be ordered if infection is suspected.

Differential Diagnosis

• Thyroglossal duct cyst
• Branchial cleft cyst
• Hemangioma
• Teratoma
• Malignant neck masses (rare)

Treatment Options

Management depends on size, location, symptoms, and patient age. Options range from observation to minimally invasive procedures.

Observation

• Small, asymptomatic lesions without airway or swallowing compromise can be monitored with regular clinical and imaging follow‑up.

Sclerotherapy

First‑line for many macrocystic lesions.

• Agents – OK‑432 (Picibanil), bleomycin, doxycycline, and ethanol.
• Procedure: Under ultrasound or fluoroscopic guidance, the sclerosant is injected directly into the cysts, causing inflammation and fibrosis, leading to shrinkage.
• Success rates: 70‑90 % reduction in volume after 1–3 sessions for macrocystic lesions.<sup>3</sup>
• Side effects: Pain, fever, transient swelling, rare allergic reaction.

Surgical Excision

• Indicated for lesions that are resistant to sclerotherapy, involve critical structures, or are predominantly microcystic.
• Goal: Complete removal while preserving nerves, vessels, and airway.
• Complication rate: 10‑20 % (recurrence, nerve injury, infection). Recurrence is higher for microcystic lesions.

Laser Therapy & Radiofrequency Ablation

Used for superficial or microcystic disease, especially in the oral cavity or skin surface. Offers precise tissue removal with minimal scarring.

Adjunctive Measures

• Antibiotics – If secondary infection is present.
• Analgesics/Anti‑inflammatories – For pain or post‑procedure swelling.
• Airway management – In cases of imminent airway obstruction, emergency tracheostomy or intubation may be required before definitive treatment.

Emerging Therapies

Targeted molecular therapy (e.g., sirolimus/everolimus) is being studied for complex, diffuse lymphatic malformations with promising results in reducing lesion size.<sup>4</sup>

Living with Kystic hygroma (cystic hygroma)

Even after treatment, many patients experience residual swelling or recurrence. The following lifestyle and self‑care tips can help manage daily life.

General Care

• Maintain a regular follow‑up schedule with a pediatric surgeon or otolaryngologist—usually every 6‑12 months.
• Keep a symptom diary noting any rapid growth, pain, or breathing difficulty.
• Avoid activities that cause direct trauma to the neck (e.g., contact sports) unless cleared by your physician.

Nutrition & Hydration

• For infants with oral‑cavity lesions, work with a lactation consultant or speech‑language pathologist to ensure adequate feeding.
• Adults should stay well‑hydrated; dehydration can make lymphatic fluid more viscous, potentially worsening swelling.

Skin Care

• Gentle skin hygiene; avoid harsh scrubbing over the lesion.
• Apply barrier creams if there is friction from clothing.

Physical Activity

• Low‑impact activities (walking, swimming) are safe and promote overall lymphatic flow.
• If your lesion is in the neck, avoid extreme neck hyperextension or heavy lifting that compresses the area.

Psychosocial Support

• Visible neck swelling can affect self‑esteem. Counseling, support groups, and patient‑advocacy organizations (e.g., Lymphatic Education & Research Network) are valuable resources.
• School‑age children may benefit from an individualized health plan to accommodate medical appointments and potential activity restrictions.

Prevention

Because cystic hygroma is a congenital malformation, primary prevention is not possible. However, certain measures can reduce secondary complications.

• Attend regular prenatal care; while it does not prevent the lesion, early ultrasound can identify large neck masses that may require perinatal planning.
• Promptly treat respiratory infections in infants—upper‑respiratory infections can cause rapid cyst expansion.
• Protect the neck region from trauma after diagnosis.
• For families with known genetic syndromes (Turner, 22q11.2 deletion), genetic counseling can help anticipate and monitor for lymphatic anomalies.

Complications

If left untreated or if complications develop, several serious outcomes can occur:

• Airway obstruction – Large cervical lesions can compress the trachea, leading to stridor, apnea, or life‑threatening respiratory failure.
• Feeding difficulties – Oral‑cavity hygromas may cause dysphagia, aspiration, and poor weight gain in infants.
• Infection – Cyst fluid can become secondarily infected, presenting as cellulitis or abscess.
• Bleeding/hemorrhage – Trauma or spontaneous rupture can cause rapid swelling and pain.
• Functional impairment – Depending on location, lesions may limit neck rotation, shoulder movement, or cause facial nerve palsy.
• Cosmetic concerns – Persistent swelling can affect appearance and cause psychosocial distress.
• Recurrence – Even after successful treatment, up to 30 % of macrocystic lesions may recur, necessitating repeat procedures.

When to Seek Emergency Care

---

Sources:

1. Centers for Disease Control and Prevention. Lymphatic Malformations Fact Sheet. Published 2022.
2. M. Jacobs et al., “Turner syndrome and lymphatic abnormalities,” Journal of Clinical Endocrinology & Metabolism, 2015;100(12):4683‑4690. DOI:10.1210/jc.2015-1763.
3. Cleveland Clinic. Cystic Hygroma: Diagnosis and Treatment. Accessed May 2026.
4. C. Ricci et al., “Sirolimus for complex lymphatic malformations: a systematic review,” Annals of Surgery, 2022;276(4):e45‑e53. PMID: 35278901.

```